Some conditions which can present with fatty liver and/or hypertransaminasemia [1, 2, 4, 5, 17, 19]

Genetic and metabolic causesToxics and drugsNutritional/GI and hepatic causes
Urea cycle disordersEthanolCeliac disease
Hereditary fructose intolerance/galactosemia/tyrosinemiaEcstasyInflammatory bowel disease
Glycogenosis I and VI and IXNifedipineIntestinal failure
Bile acids synthesis defectsDiltiazemDysbiosis
Citrin deficiencyCocaineViral hepatitis (HCV and HBV)
Cystic fibrosisSolventsAutoimmune hepatitis
Schwachman-Diamond syndromePesticidesKwashiorkor/malnutrition
Wilson’s diseaseGlucocorticoidsAnorexia nervosa
Lipid storage disease
Niemann-Pick disease type C
EstrogensRapid weight loss
Abeta/hypobetalipoproteinemiaSodium valproateParenteral nutrition
Mitochondrial, fatty acids°
α- and β-oxidation defects*
ER function (e.g., CDG) or protein metabolism disordersAmiodaronePCOS
Alpha 1-AT deficiencyTetracyclineOSAS
NBASL-asparaginaseEndocrine causes
Turner syndromeAspirinHypothyroidism
LipodystrophiesAntipsychoticsHypothalamic-pituitary disorders
Porphyria cutanea tardaAntidepressantsDiabetes mellitus type 1 (Mauriac syndrome)
Familial hyperlipoproteinemiaAntiretroviral drugsSepsis
Porto-systemic shuntVitamin EOthers
Some myopathic disorders

MCADD, LCHAD, VLCHAD, MADD; *mitochondria and other organelle dysfunction leading to the accumulation of fat droplets, and peroxisomal defects, frequently microvacuolar; Alpha 1-AT: alpha 1-antitrypsin; CDG: congenital disorders of glycosylation; ER: endoplasmic reticulum; NBAS: neuroblastoma amplified sequence; OSAS: obstructive sleep apnea syndrome; PCOS: polycystic ovarian syndrome; MCADD: medium-chain acyl-CoA dehydrogenase deficiency; LCHAD: long-chain 3-hydroxyacyl-CoA dehydrogenase; VLCHAD: very long-chain 3-hydroxyacyl-CoA dehydrogenase; MADD: multiple acyl-CoA dehydrogenase deficiency